Prognostic impact of PD-L1 expression in primary gastric and intestinal diffuse large B-cell lymphoma-Reference-Cited by-同舟云学术

Prognostic impact of PD-L1 expression in primary gastric and intestinal diffuse large B-cell lymphoma

Published:2019-09-06 Issue:1 Volume:55 Page:39-50
ISSN:0944-1174
Container-title:Journal of Gastroenterology
language:en
Short-container-title:J Gastroenterol

Author:

Ishikawa Eri^ORCID,Nakamura Masanao,Shimada Kazuyuki,Tanaka Tsutomu,Satou Akira,Kohno Kei,Sakakibara Ayako,Furukawa Kazuhiro,Yamamura Takeshi,Miyahara Ryoji,Nakamura Shigeo,Kato Seiichi,Fujishiro Mitsuhiro

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology

Link

http://link.springer.com/content/pdf/10.1007/s00535-019-01616-3.pdf

Reference39 articles.

1. Nakamura S, Matsumoto T, Iida M, et al. Primary gastrointestinal lymphoma in Japan—a clinicopathologic analysis of 455 patients with special reference to its time trends. Cancer. 2003;97:2462–73.

2. Papaxoinis G, Papageorgiou S, Rontogianni D, et al. Primary gastrointestinal non-Hodgkin's lymphoma: a clinicopathologic study of 128 cases in Greece. A Hellenic Cooperative Oncology Group study (HeCOG). Leuk Lymphoma. 2006;47:2140–6.

3. Ding WS, Zhao S, Wang JC, et al. Gastrointestinal lymphoma in Southwest China: subtype distribution of 1,010 cases using the WHO (2008) classification in a single institution. Acta Haematol. 2016;135:21–8.

4. Vetro C, Romano A, Amico I, et al. Endoscopic features of gastro-intestinal lymphomas: from diagnosis to follow-up. World J Gastroenterol. 2014;20:12993–3005.

5. Kuo SH, Yeh KH, Chen LT, et al. Helicobacter pylori-related diffuse large B-cell lymphoma of the stomach: a distinct entity with lower aggressiveness and higher chemosensitivity. Blood Cancer J. 2014;4:7.

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Primary intestinal diffuse large B-cell lymphoma: novel insights and clinical perception;Frontiers in Oncology;2024-08-15

2. Programmed Death Ligand 1 (PD-L1) Expression in Lymphomas: State of the Art;International Journal of Molecular Sciences;2024-06-11

3. Cystatin SN (CST1) Is a Poor Independent Prognostic Biomarker for Gastrointestinal Diffuse Large B-cell Lymphoma;Medical Science Monitor;2024-05-30

4. Non-neoplastic cells as prognostic biomarkers in diffuse large B-cell lymphoma: A system review and meta-analysis;Tumori Journal;2024-01-05

5. Advances in diagnosis, treatment and prognostic factors of gastrointestinal DLBCL;Leukemia Research;2023-12